Sonic hedgehog protein promotes bone marrow-derived endothelial progenitor cell proliferation, migration and VEGF production via Pl 3-kinase/Akt signaling pathways

被引:51
作者
Fu, Jin-Rong
Liu, Wen-Li [1 ]
Zhou, Jian-Feng
Sun, Han-Ying
Xu, Hui-Zhen
Luo, Li
Zhang, Heng
Zhou, Yu-Feng
机构
[1] Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Dept Pediat, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China
关键词
mouse Sonic hedgehog protein; endothelial cells; stem cells; protein kinase C; 1-phos-phatidylinositol; 3-kinase; vascular endothelial growth factor A; cell proliferation; emigration; immigration;
D O I
10.1111/j.1745-7254.2006.00335.x
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Aim: To investigate the effects of Sonic hedgehog (shh) protein on bone marrow-derived endothelial progenitor cells (BM-EPC) proliferation, migration and vascular endothelial growth factor (VEGF) production, and the potential signaling pathways involved in these effects. Methods: Bone marrow-derived Flk-1+ cells were enriched using the MACS system from adult Kunming mice and then BM-EPC was cultured in gelatin-coated culture dishes. The effects of shh N-terminal pep-tide on BM-EPC proliferation were evaluated using the MTT colorimetric assay. Cell migration was assayed using a modified Boy den chamber technique. The production of VEGF was determined by ELISA and immunofluorescence analysis. The potential involvement of PKC and PI3K signaling pathways was explored using selective inhibitor or Western blot. Results: The proliferation, migration and VEGF production in BM-EPC could be promoted by endogenous shh N-terminal peptide at concentrations of 0.1 ug/mL to 10 ug/mL, and could be inhibited by anti-shh antibodies. Shh-mediated proliferation and migration in BM-EPC could be partly attenuated by anti-VEGF. Phospho-PI3 -kinase expression in newly separated BM-EPC was low, and it increased significantly when exogenous shh N-terminal peptide was added, but could be attenuated by anti-human/mouse shh N-terminal peptide antibody. Moreover, the inhibitor of the PI3-kinase, but not the inhibitor of the PKC, significantly inhibited the shh-mediated proliferation, migration and VEGF production. Conclusion: Shh protein can stimulate bone marrow-derived BM-EPC proliferation, migration and VEGF production, which may promote neovascularization to ischemic tissues. This results also suggests that the PI3-kinase/Akt signaling pathways are involved in the angiogenic effects of shh.
引用
收藏
页码:685 / 693
页数:9
相关论文
共 26 条
[1]
Mobilizing endothelial progenitor cells [J].
Aicher, A ;
Zeiher, AM ;
Dimmeler, S .
HYPERTENSION, 2005, 45 (03) :321-325
[2]
Endothelial progenitor cells for postnatal vasculogenesis [J].
Asahara, T ;
Kawamoto, A .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (03) :C572-C579
[3]
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells [J].
Asahara, T ;
Takahashi, T ;
Masuda, H ;
Kalka, C ;
Chen, DH ;
Iwaguro, H ;
Inai, Y ;
Silver, M ;
Isner, JM .
EMBO JOURNAL, 1999, 18 (14) :3964-3972
[4]
Therapeutic potential of endothelial progenitor cells in cardiovascular diseases [J].
Dzau, VJ ;
Gnecchi, M ;
Pachori, AS ;
Morello, F ;
Melo, LG .
HYPERTENSION, 2005, 46 (01) :7-18
[5]
Therapeutic neovascularization by autologous transplantation with expanded endothelial progenitor cells from peripheral blood into ischemic hind limbs [J].
Fan, CL ;
Gao, PJ ;
Che, ZQ ;
Liu, JJ ;
Wei, J ;
Zhu, DL .
ACTA PHARMACOLOGICA SINICA, 2005, 26 (09) :1069-1075
[6]
[付劲蓉 Fu Jingrong], 2005, [中华血液学杂志, Chinese Journal of Hematology], V26, P352
[7]
Fu JR, 2005, CHINESE MED J-PEKING, V118, P1979
[8]
Gehling UM, 2000, BLOOD, V95, P3106
[9]
Hedgehog signaling induces cardiomyogenesis in P19 cells [J].
Gianakopoulos, PJ ;
Skerjanc, IS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (22) :21022-21028
[10]
Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance [J].
Hristov, M ;
Weber, C .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2004, 8 (04) :498-508